Skip to main content
. 2014 Dec 8;35(1):22–27. doi: 10.3343/alm.2015.35.1.22

Table 1.

The frequency of JAK2 V617F, MPL W515, and CALR mutations

graphic file with name alm-35-22-i001.jpg

*One ET patient had both CALR and JAK2 V617F mutations; Negative for JAK2 (V617F and exon 12 mutation), MPL W515, and CALR mutation.

Abbreviations: JAK2, Janus kinase 2; MPL, myeloproliferative leukemia virus oncogene; CALR, calreticulin; PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis.